VYNE Therapeutics Inc.VYNENASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank49
Year-over-Year Change
Year-over-year debt growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P49
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
110.02%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | -100.00% |
| Q2 2025 | -60.32% |
| Q1 2025 | -36.36% |
| Q4 2024 | -19.51% |
| Q3 2024 | -15.17% |
| Q2 2024 | -19.44% |
| Q1 2024 | -15.89% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | -100.00% |
| Q2 2022 | -73.50% |
| Q1 2022 | -66.48% |
| Q4 2021 | -66.83% |
| Q3 2021 | -96.96% |
| Q2 2021 | -0.24% |
| Q1 2021 | -0.23% |
| Q4 2020 | -1.20% |
| Q3 2020 | -0.74% |
| Q2 2020 | 2.65% |
| Q1 2020 | 4836.29% |
| Q4 2019 | -18.89% |
| Q3 2019 | -15.06% |
| Q2 2019 | 48.54% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |